In Brief: Creutzfeldt-Jakob disease
Executive Summary
Creutzfeldt-Jakob disease: Risks associated with transmission of rare neurological disorder by blood products will be discussed by an ad hoc FDA advisory committee June 22. The meeting will be held at the Bethesda, Md. Marriott beginning at 8 a.m....